6848 logo

RBC Bioscience TPEX:6848 Stock Report

Last Price

NT$17.60

Market Cap

NT$228.4m

7D

8.6%

1Y

3.5%

Updated

14 Jun, 2024

Data

Company Financials

RBC Bioscience Corporation

TPEX:6848 Stock Report

Market Cap: NT$228.4m

6848 Stock Overview

Researches, develops, manufactures, and sells reagents and devices for life science and molecular diagnosis in Europe, the United States, Asia, Taiwan, Africa, and Australia.

6848 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance4/6
Financial Health1/6
Dividends3/6

RBC Bioscience Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for RBC Bioscience
Historical stock prices
Current Share PriceNT$17.60
52 Week HighNT$18.90
52 Week LowNT$13.55
Beta0.017
1 Month Change8.31%
3 Month Change10.69%
1 Year Change3.53%
3 Year Changen/a
5 Year Changen/a
Change since IPO-63.88%

Recent News & Updates

Recent updates

Shareholder Returns

6848TW Life SciencesTW Market
7D8.6%2.8%1.9%
1Y3.5%-21.1%27.4%

Return vs Industry: 6848 exceeded the TW Life Sciences industry which returned -21.1% over the past year.

Return vs Market: 6848 underperformed the TW Market which returned 27.4% over the past year.

Price Volatility

Is 6848's price volatile compared to industry and market?
6848 volatility
6848 Average Weekly Movement3.5%
Life Sciences Industry Average Movement4.4%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.4%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 6848 has not had significant price volatility in the past 3 months.

Volatility Over Time: 6848's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1995n/an/awww.rbcbioscience.com

RBC Bioscience Corporation researches, develops, manufactures, and sells reagents and devices for life science and molecular diagnosis in Europe, the United States, Asia, Taiwan, Africa, and Australia. It offers molecular biomedical diagnostic and research reagents, gene extraction automatic testing instruments, and gene extraction reagent tissues; automated nucleic acid extractors; and nucleic acid extraction kits. The company sells its products through distributors.

RBC Bioscience Corporation Fundamentals Summary

How do RBC Bioscience's earnings and revenue compare to its market cap?
6848 fundamental statistics
Market capNT$228.37m
Earnings (TTM)NT$6.43m
Revenue (TTM)NT$172.47m

35.5x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6848 income statement (TTM)
RevenueNT$172.47m
Cost of RevenueNT$99.57m
Gross ProfitNT$72.90m
Other ExpensesNT$66.47m
EarningsNT$6.43m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.50
Gross Margin42.27%
Net Profit Margin3.73%
Debt/Equity Ratio195.4%

How did 6848 perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

89%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.